Opinions
Benj Gallander
Noveko International Inc.
EKO-T
DON'T BUY
Jun 12, 2009
Did a number of acquisitions over the past few years. Very difficult to integrate a number of companies, without involving a lot of losses and write-offs. They keep on losing money and it wouldn't surprise him to see this continue for a few more years.
$2.210
Stock price when the opinion was issued
biotechnology
pharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.